Delivery Order SPE2DB24D1205-SPE2DB24FCQWF
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $1,565.03 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lacosamide 10 mg/ml solution in 200 ml vials. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceuticals and medical supplies to support...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,706.40 order is for the delivery of 60 tablets of the medication lacosamide 150 mg. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of $999,999,999.00 and a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,361.54 Firm Fixed Price Delivery Order contract is for the supply of Lacosamide 10 mg/ml solution, a specialty medication. The contract has a period of performance through June 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $7,970.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a specific medication - Lacosamide 10 mg/ml Solution 200ml. The contract is a Delivery Order valued at $1,853.59 and has a completion date of July 30, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a $999,999,999 IDC...
- This federal contract award, valued at $1,808.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of 4564638990 - Lacosamide 10 mg/ml solution 200ml, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of May 20, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a major supplier...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lacosamide 50 mg/5 ml cup unit dose 5 ml. The contract has a potential value of $2,250.27 and a completion date of March 6, 2024. This delivery order is part of an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $25,129.86. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563830313 - Lacosamide 10 mg/ml solution 200 ml. The contract has a completion date of March 4, 2024 and a potential value of $1,450.26. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery contract (IDC) between...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $19,479.16 to Amerisourcebergen Drug Corp, the Corporate Office division of the Amerisourcebergen Corporation. This contract is a Firm Fixed Price delivery order placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCQWFDelivery Order
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,177.78 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Lacosamide 10 mg/ml solution in 200ml bottles. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 7/29/24, 9:28 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/29/24 |